4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™ - Concepedia

Concepedia

Publication | Open Access

4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™

DOI Full Paper Access

16

Citations

15

References

2003

Year

Patrick Angibaud, Ashis Saha, Xavier Bourdrez, David W. End, Eddy Freyne, Patricia Lezouret, Geert Mannens, Laurence Mévellec, Christophe Meyer, Isabelle Pilatte,

Bioorganic & Medicinal Chemistry Letters

HeterocyclicBiochemistryNatural SciencesMedicine4-Methyl-1,2,4-triazol-3-yl HeterocycleOrganic Chemistry1-Methylimidazol-5-yl MoietyHeterocycle ChemistryChemical BiologyPharmacologyPharmaceutical ChemistryDrug Discovery

References

	Year	Citations

Page 1

Page 1